ArticleAnnals of thoracic surgery short reports2026
Single-Center Initial Experience with Robotic Assisted Minimally Invasive Coronary Artery Bypass Surgery.
Article in Annals of thoracic surgery short reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Robotic assisted minimally invasive direct coronary artery bypass grafting (RA-MIDCAB) represents an effective alternative to conventional coronary artery bypass grafting for revascularization of the left anterior descending artery (LAD) with the left internal thoracic artery (LITA). The first LITA-LAD bypass using a robot was performed in 1998. Since then, progress has been made, bringing the benefits of reduced surgical trauma and faster patient recovery. We report on our single-center initial experience of RA-MIDCAB surgery. Methods: This retrospective study included the first 27 patients who underwent RA-MIDCAB between July 2024 and September 2025. Baseline characteristics, perioperative and postoperative outcomes were collected from institutional databases and patient records. Results: All RA-MIDCAB procedures were successfully performed by 2 expert surgeons. Intraoperative graft patency was measured. No mortality was registered, neither on 30-day nor long-term. Conversion to sternotomy never occurred. The mean surgery time was 245.7 minutes. Early outcomes included postoperative new onset atrial fibrillation (n = 2; 7.4%) and respiratory failure (n = 1; 3.7%). Mean length of intensive care unit stay and hospital stay were, respectively, 2.4 and 3.9 days. No patients underwent repeat revascularization or suffered major adverse cardiovascular events. Conclusions: RA-MIDCAB surgery can be performed safely with excellent results. Despite an initial investment, starting a RA-MIDCAB program improves quality of care.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.